2.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IBRX Giù?
Forum
Previsione
Immunitybio Inc Borsa (IBRX) Ultime notizie
Will ImmunityBio Inc. stock outperform tech sector in 2025Market Sentiment Report & Technical Entry and Exit Alerts - Trung tâm Dự báo KTTV quốc gia
Is ImmunityBio Inc. stock a buy on dipsWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Will ImmunityBio Inc. stock split again soon2025 Trading Volume Trends & Technical Entry and Exit Tips - Trung tâm Dự báo KTTV quốc gia
How ImmunityBio Inc. stock reacts to job market data2025 Market Trends & Weekly Market Pulse Alerts - Trung tâm Dự báo KTTV quốc gia
Can machine learning forecast ImmunityBio Inc. recovery2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Institution Moves: Will ImmunityBio Inc. stock outperform tech sector in 20252025 Support & Resistance & Stepwise Swing Trade Plans - Trung tâm Dự báo KTTV quốc gia
Discover ImmunityBio And Two Other Growth Stocks With High Insider Ownership - simplywall.st
Short interest data insights for ImmunityBio Inc.Global Markets & Free High Return Stock Watch Alerts - newser.com
Is ImmunityBio Inc a good long term investmentResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in
ImmunityBio Inc. stock trend outlook and recovery pathJuly 2025 Volume & Community Verified Trade Signals - newser.com
Tick level data insight on ImmunityBio Inc. volatility2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com
Will ImmunityBio Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Will ImmunityBio Inc. rebound enough to break evenBear Alert & Community Consensus Picks - newser.com
How to recover losses in ImmunityBio Inc. stockJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-11 12:10:43 - earlytimes.in
ImmunityBio, Inc.Common Stock (NQ: IBRX - FinancialContent
Why Immunitybio Inc. (IBRX) Soared on Thursday - MSN
ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - MSN
Why ImmunityBio Inc. (26CA) stock is a strong analyst pick2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com
ImmunityBio, Inc. (26CA.F) stock price, news, quote and history - Yahoo
Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews
IBRX stockholders via consent approve 1.65B common share authorization - Stock Titan
Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
ImmunityBio Inc. stock retracement – recovery analysis2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
ANKTIVA Reimbursement Gains and UK Approval Might Change The Case For Investing In ImmunityBio (IBRX) - Sahm
ImmunityBio, Inc. (NASDAQ:IBRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView
ImmunityBio: A Small Bet Is Warranted (NASDAQ:IBRX) - Seeking Alpha
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Does ImmunityBio Inc. show high probability of reboundJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com
What MACD and RSI say about ImmunityBio Inc.July 2025 Retail & Weekly High Return Stock Opportunities - newser.com
ImmunityBio (IBRX): Revisiting Valuation After ANKTIVA’s Regulatory Wins and New Growth Initiatives - Sahm
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):